PRAX vs TMUS · $7.38B cap vs P/E 19, rev $22.79B
Praxis Precision Medicines Inc (PRAX) versus T-Mobile US Inc (TMUS) — a side-by-side from cached financials, not a winner call.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
T-Mobile US Inc (TMUS) is a telecom services company listed on NASDAQ. It is led by Mike Sievert.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
Latest reported TMUS revenue for 2026-06-30 was $22.79B. Net income was $3.24B. Revenue was down 1.4% from 2026-03-31 to 2026-06-30. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
PRAX currently screens at market cap $7.38B. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
Not investment advice. Open the PRAX and TMUS stock pages for the full models.
Not investment advice.